You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 21, 2026

Carb - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

Drug Prices for carb

See drug prices for carb

Generic filers with tentative approvals for CARB

Applicant	Application No.	Strength	Dosage Form
⤷ Get Started Free	⤷ Get Started Free	300MG	CAPSULE, EXTENDED RELEASE; ORAL
⤷ Get Started Free	⤷ Get Started Free	200MG	CAPSULE, EXTENDED RELEASE; ORAL
⤷ Get Started Free	⤷ Get Started Free	100MG	CAPSULE, EXTENDED RELEASE; ORAL

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

US Patents and Regulatory Information for carb

+ Get email alerts for changes to this table

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Aton	LODOSYN	carbidopa	TABLET;ORAL	017830-001	Approved Prior to Jan 1, 1982	AB	RX	Yes	Yes	⤷ Get Started Free	⤷ Get Started Free				⤷ Get Started Free
Impax	CREXONT	carbidopa; levodopa	CAPSULE, EXTENDED RELEASE;ORAL	217186-004	Aug 7, 2024		RX	Yes	Yes	⤷ Get Started Free	⤷ Get Started Free				⤷ Get Started Free
Actavis Totowa	CARBOPLATIN	carboplatin	INJECTABLE;INTRAVENOUS	078732-001	Feb 6, 2012		DISCN	No	No	⤷ Get Started Free	⤷ Get Started Free				⤷ Get Started Free
Rubicon Research	CARBIDOPA AND LEVODOPA	carbidopa; levodopa	TABLET;ORAL	216505-001	Sep 21, 2022	AB	RX	No	No	⤷ Get Started Free	⤷ Get Started Free				⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.